Watchlist Price Alert

Celldex Therapeutics Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

20.40

-0.86 (-4.05%)

At close: Jun 16, 2025, 3:59 PM

20.16

-1.15%

After-hours: Jun 16, 2025, 07:22 PM EDT

Celldex Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	7.02M	6.88M	2.36M	4.65M	7.42M	3.57M	9.54M	12.74M	6.79M
Cost of Revenue	n/a	3.01M	1.4M	3.07M	42.53M	42.67M	66.45M	96.17M	102.03M
Gross Profit	7.02M	3.88M	957K	1.58M	-35.12M	-39.1M	-56.91M	-83.43M	-95.24M
Operating Income	-195.08M	-154.54M	-115.23M	-71.24M	-63.35M	-55.03M	-156.44M	-121.53M	-132.92M
Interest Income	n/a	13.11M	n/a	505K	2.41M	4.15M	n/a	n/a	n/a
Pretax Income	-157.86M	-141.43M	-112.33M	-70.74M	-60.95M	-50.88M	-151.95M	-117.31M	-128.53M
Net Income	-157.86M	-141.43M	-122.78M	-70.51M	-59.78M	-50.37M	-151.18M	-93.03M	-128.53M
Selling & General & Admin	38.55M	30.91M	27.2M	20.49M	14.46M	15.43M	19.27M	25M	35.98M
Research & Development	163.55M	118.01M	82.26M	53.31M	42.53M	42.67M	66.45M	96.17M	102.73M
Other Expenses	n/a	12.5M	90.34M	55.38M	54.02M	42.7M	224K	896K	997K
Operating Expenses	202.1M	161.43M	109.45M	73.8M	56.99M	58.1M	85.94M	122.07M	139.7M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	151.09M	15.97M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	202.1M	161.43M	109.45M	73.8M	56.99M	58.1M	85.94M	122.07M	139.7M
Income Tax Expense	n/a	n/a	10.46M	-227K	-1.17M	-506K	-765K	-24.28M	-8.77M
Shares Outstanding (Basic)	64.39M	48.45M	46.89M	42.87M	29.64M	14.51M	10.44M	8.57M	6.77M
Shares Outstanding (Diluted)	64.39M	48.45M	46.89M	42.87M	29.64M	14.51M	10.44M	8.57M	6.77M
EPS (Basic)	-2.45	-2.92	-2.62	-1.64	-2.02	-3.47	-14.48	-10.86	-18.99
EPS (Diluted)	-2.45	-2.92	-2.62	-1.64	-2.02	-3.47	-14.48	-10.86	-18.99
EBITDA	-191.9M	-139.03M	-104.2M	-66.08M	-45.64M	-49.67M	-72.6M	-104.02M	-124.44M
EBIT	-195.08M	-142.04M	-107.1M	-69.15M	-49.57M	-54.52M	-76.4M	-109.33M	-132.92M
Depreciation & Amortization	3.18M	3.01M	1.4M	3.07M	2M	4.86M	3.8M	5.31M	4.09M